Enteric Coating as a Factor in Aspirin Resistance

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Cardiovascular Disease
Interventions
DRUG

Plain aspirin

Plain aspirin 75 mg or 150 mg

Trial Locations (1)

Unknown

Beaumont Hospital, Dublin

All Listed Sponsors
collaborator

Irish Heart Foundation

OTHER

lead

Royal College of Surgeons, Ireland

OTHER

NCT00531362 - Enteric Coating as a Factor in Aspirin Resistance | Biotech Hunter | Biotech Hunter